BRAF/MEK inhibition induces cell state transitions boosting immune checkpoint sensitivity in BRAFV600E-mutant glioma
2025 · Cell Reports Medicine · 2 citations
https://doi.org/10.1016/j.xcrm.2025.102183
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
21
Papers
16
Citations
3
h-index
0
i10-index
Emon Nasajpour is an academic researcher from Stanford Medicine. The author has contributed to research in topics: Glioma Diagnosis and Treatment & Melanoma and MAPK Pathways & Neuroblastoma Research and Treatments. The author has an h-index of 3, co-authored 18 publications.
https://doi.org/10.1016/j.xcrm.2025.102183
https://doi.org/10.64898/2026.02.19.26345901
Click to start Chat